These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 20049656)
21. Retinoic acid-mediated phospholipase A2 signaling in the nucleus. Farooqui AA; Antony P; Ong WY; Horrocks LA; Freysz L Brain Res Brain Res Rev; 2004 Jul; 45(3):179-95. PubMed ID: 15210303 [TBL] [Abstract][Full Text] [Related]
22. Plasmalogen attenuates the development of hepatic steatosis and cognitive deficit through mechanism involving p75NTR inhibition. Liu Y; Cong P; Zhang T; Wang R; Wang X; Liu J; Wang X; Xu J; Wang Y; Wang J; Xue C Redox Biol; 2021 Jul; 43():102002. PubMed ID: 33984602 [TBL] [Abstract][Full Text] [Related]
23. Plasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatin. Khan M; Singh J; Singh I J Neurochem; 2008 Aug; 106(4):1766-79. PubMed ID: 18540993 [TBL] [Abstract][Full Text] [Related]
24. Differential roles of cyclooxygenase isoforms after kainic acid-induced prostaglandin E(2) production and neurodegeneration in cortical and hippocampal cell cultures. Kim EJ; Lee JE; Kwon KJ; Lee SH; Moon CH; Baik EJ Brain Res; 2001 Jul; 908(1):1-9. PubMed ID: 11457426 [TBL] [Abstract][Full Text] [Related]
25. Alterations in the Levels of Amyloid-β, Phospholipid Hydroperoxide, and Plasmalogen in the Blood of Patients with Alzheimer's Disease: Possible Interactions between Amyloid-β and These Lipids. Yamashita S; Kiko T; Fujiwara H; Hashimoto M; Nakagawa K; Kinoshita M; Furukawa K; Arai H; Miyazawa T J Alzheimers Dis; 2016; 50(2):527-37. PubMed ID: 26682681 [TBL] [Abstract][Full Text] [Related]
26. Phospholipase A2 activities with a plasmalogen substrate in brain and in neural tumor cells: a sensitive and specific assay using pyrenesulfonyl-labeled plasmenylethanolamine. Hirashima Y; Mills JS; Yates AJ; Horrocks LA Biochim Biophys Acta; 1990 Oct; 1047(1):35-40. PubMed ID: 2174264 [TBL] [Abstract][Full Text] [Related]
27. Activation and solubilization by Triton X-100 of membrane-bound phospholipase D of rat brain. Kanoh H; Kanaho Y; Nozawa Y Lipids; 1991 Jun; 26(6):426-30. PubMed ID: 1881239 [TBL] [Abstract][Full Text] [Related]
28. Functions, structures and Triton X-100 effect for the catalytic subunits of heterodimeric phospholipases A2 from Vipera nikolskii venom. Gao W; Starkov VG; He ZX; Wang QH; Tsetlin VI; Utkin YN; Lin ZJ; Bi RC Toxicon; 2009 Nov; 54(6):709-16. PubMed ID: 19500614 [TBL] [Abstract][Full Text] [Related]
29. Differential effects of calcium-dependent and calcium-independent phospholipase A(2) inhibitors on kainate-induced neuronal injury in rat hippocampal slices. Lu XR; Ong WY; Halliwell B; Horrocks LA; Farooqui AA Free Radic Biol Med; 2001 Jun; 30(11):1263-73. PubMed ID: 11368924 [TBL] [Abstract][Full Text] [Related]
30. Plasmalogen mediates integration of adherens junction. Takahashi T; Honsho M; Abe Y; Fujiki Y J Biochem; 2019 Nov; 166(5):423-432. PubMed ID: 31236591 [TBL] [Abstract][Full Text] [Related]
31. Oral Administration of Ethanolamine Glycerophospholipid Containing a High Level of Plasmalogen Improves Memory Impairment in Amyloid β-Infused Rats. Yamashita S; Hashimoto M; Haque AM; Nakagawa K; Kinoshita M; Shido O; Miyazawa T Lipids; 2017 Jul; 52(7):575-585. PubMed ID: 28551706 [TBL] [Abstract][Full Text] [Related]
32. Studies of myo-inositol and plasmalogen metabolism in rat brain. Hoffman-Kuczynski B; Reo NV Neurochem Res; 2004 Apr; 29(4):843-55. PubMed ID: 15098950 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of phospholipase A₂ in rat brain modifies different membrane fluidity parameters in opposite ways. Schaeffer EL; Skaf HD; Novaes Bde A; da Silva ER; Martins BA; Joaquim HD; Gattaz WF Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1612-7. PubMed ID: 21601609 [TBL] [Abstract][Full Text] [Related]
34. Secretory phospholipase A2 activity in the normal and kainate injected rat brain, and inhibition by a peptide derived from python serum. Thwin MM; Ong WY; Fong CW; Sato K; Kodama K; Farooqui AA; Gopalakrishnakone P Exp Brain Res; 2003 Jun; 150(4):427-33. PubMed ID: 12707747 [TBL] [Abstract][Full Text] [Related]
35. The rapid and reversible activation of a calcium-independent plasmalogen-selective phospholipase A2 during myocardial ischemia. Ford DA; Hazen SL; Saffitz JE; Gross RW J Clin Invest; 1991 Jul; 88(1):331-5. PubMed ID: 2056126 [TBL] [Abstract][Full Text] [Related]
36. Deficiency in ethanolamine plasmalogen leads to altered cholesterol transport. Munn NJ; Arnio E; Liu D; Zoeller RA; Liscum L J Lipid Res; 2003 Jan; 44(1):182-92. PubMed ID: 12518037 [TBL] [Abstract][Full Text] [Related]
37. The role of phospholipase A2 in neuronal homeostasis and memory formation: implications for the pathogenesis of Alzheimer's disease. Forlenza OV; Schaeffer EL; Gattaz WF J Neural Transm (Vienna); 2007 Feb; 114(2):231-8. PubMed ID: 17131232 [TBL] [Abstract][Full Text] [Related]
38. Plasmalogens, docosahexaenoic acid and neurological disorders. Farooqui AA; Ong WY; Horrocks LA Adv Exp Med Biol; 2003; 544():335-54. PubMed ID: 14713251 [No Abstract] [Full Text] [Related]
39. Effects of glycosaminoglycans and glycosphingolipids on cytosolic phospholipases A2 from bovine brain. Yang HC; Farooqui AA; Horrocks LA Biochem J; 1994 Apr; 299 ( Pt 1)(Pt 1):91-5. PubMed ID: 8166664 [TBL] [Abstract][Full Text] [Related]
40. [Effect of piracetam on neuronal and synaptosomal phospholipase A2 activity]. Woelk H Arzneimittelforschung; 1979; 29(4):615-7. PubMed ID: 582756 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]